Cadwalader Advises AngioDynamics in its $100 million Sale of Certain Assets to Merit Medical Systems

June 12, 2023

Cadwalader advised longtime client AngioDynamics in the sale of its Dialysis product portfolio and BioSentry Tract Sealant System Biopsy product to Merit Medical Systems, Inc. for $100 million in cash. AngioDynamics intends to use net proceeds from the sale to eliminate its existing debt and support further strategic investments in growth and profitability.

Merit Medical Systems, Inc. is a global manufacturer and marketer of healthcare technology. Merit serves hospitals worldwide with a domestic and international sales force and clinical support team totaling in excess of 700 individuals.

AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients.

The Cadwalader team was led by Corporate co-chair William Mills and partner Braden McCurrach and includes associates Peter Bariso and Christal McCamy, Tax partner Linda Swartz and associate William Walsh, Finance partner Chris McDermott and associate Will Kroske and IP partner Danielle Tully, special counsel Howard Wizenfeld and associate Jennifer Rabbino.

For more information, click here.